Bunge Global Sa

Bunge sold $16.9B of crops last year and kept 1.9% as profit.

If you own BG, watch the 1.9% profit slice, not the crop headlines.

bg

consumer · agribusiness large cap updated jan 9, 2026
$89.36
market cap ~$17B · 52-week range $67–$100
xvary composite: 51 / 100 · below average
our overall rating — combines growth, value, risk, and momentum
Start here if you're new
what it is
Bunge buys, processes, and ships crops, then sells oils, meal, and grains worldwide.
how it gets paid
Last year Bunge Global made $16.9B in revenue. Agribusiness was the main engine at $12.28B, or 73% of sales.
why it's growing
Revenue grew 9.0% last year. Demand for food will surely increase, as the earth's population remains on a steady, upward trajectory.
what just happened
Bunge posted $12.1B of revenue, but EPS came in at $0.49 and gross margin was 8.4%.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
30/100 earnings predictability — expect surprises
14.6x trailing p/e — the market's not buying it — or you found a deal
3.2% dividend yield — cash in your pocket every quarter
9.5% return on capital — nothing to write home about
xvary composite: 51/100 — below average
What they do
Bunge buys, processes, and ships crops, then sells oils, meal, and grains worldwide.
Bunge wins on size. It handled $16.9B of revenue, and 72.7% came from agribusiness. That means it can move crops cheaper, because big networks spread costs across more bushels. You are also buying a built-in network of elevators, ports, and crushers, and that makes leaving painful.
consumer mid-cap processor viterra global-trade
How they make money
$16.9B annual revenue · their business grew +9.0% last year
Agribusiness
$12.28B
Refined & Specialty Oils
$4.06B
Milling
$0.49B
Other
$0.07B
The products that matter
trades agricultural commodities
Commodity merchandising
inside the $16.9B revenue base
this is the volume engine. the snapshot does not break it out separately, but it sits inside the same $16.9B revenue line that keeps the network utilized.
volume
processes oilseeds and grains
Processing
part of a 1.5% margin business
processing is where scale is supposed to matter. the problem is the company-wide net margin is still just 1.5%, so you do not have much room for bad spreads or operating mistakes.
margin pressure
moves crops globally
Logistics network
supports the full $16.9B line
the network is the asset. it is also the risk surface. tariffs, trade frictions, and legal issues hit harder when your whole model depends on product moving smoothly across borders.
infrastructure moat
Key numbers
3.2%
dividend yield
You get paid 3.2% while you wait. That is bigger than the 1.5% projected earnings growth, so cash return matters more than growth.
$9.8B
long-term debt
Debt is 36% of capital, so leverage is real but not reckless.
7.5%
operating margin
This is the profit left after operating costs. At 7.5%, a small cost shock matters.
9.5%
return on capital
You get 9.5 cents of operating profit for each dollar invested. That is decent, not elite.
Financial health
B++
strength
  • balance sheet grade B++ — above average financial health
  • risk rank 3 — safer than 50% of stocks
  • price stability 70 / 100
  • long-term debt $9.8B (36% of capital)
  • net profit margin 1.9% — keeps 2 cents of every dollar in revenue
  • return on equity 13% — $0.13 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total return vs. market

You invested $10,000 in BG 3 years ago → it's now worth $9,780.

The index would have given you $13,920.

source: institutional data · total return
What just happened
missed estimates
Bunge posted $12.1B of revenue, but EPS came in at $0.49 and gross margin was 8.4%.
Revenue jumped 176% vs. prior year after Viterra, but EPS fell 89%. You got scale first, profit second.
$17.5B
revenue
$0.49
eps
8.4%
gross margin
the number that mattered
The 8.4% gross margin mattered most. It shows how little room Bunge has before costs eat the crop.
source: company earnings report, 2026

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.

weekly updates earnings alerts plain english no spam
What could go wrong

the top risk is trade-policy shocks and legal friction across a global grain-and-oilseed network.

med
thin margins leave very little room for error
a 1.5% net margin means bunge does not need a disaster to disappoint you. a small hit to processing spreads, logistics costs, or execution can do the job.
when you keep about 2 cents on the dollar, even a modest operating miss can squeeze earnings hard.
med
litigation and regulatory pressure
the page already flags antitrust and environmental litigation. for a business that depends on cross-border flow and processing assets, legal friction is not just a headline risk.
legal costs and operating restrictions would hit a business already carrying $9.8B in long-term debt.
med
trade and tariff disruption
bunge's edge is global movement of crops and ingredients. tariffs, export restrictions, or geopolitical bottlenecks can break the efficiency the model needs.
this risk runs straight through the full $16.9B revenue line shown in the snapshot.
with just a 1.5% net margin on $16.9B of revenue, any disruption to the network hits earnings faster than it would at a higher-margin business.
source: institutional data · regulatory filings · risk analysis
Pay attention to
key metric
whether EPS actually rebounds to $8.15
the stock looks cheaper on the forward number than the trailing one. if earnings do not recover, the valuation story gets weaker fast.
trend
the gap between revenue growth and profit growth
quarterly revenue rose 13% from the prior year, but full-year EPS fell 24%. that gap is the story, not the sales headline.
risk
trade-policy and litigation headlines
this business depends on smooth global movement. legal or policy friction matters more here than it does for a domestic-only operator.
next check
institutional flow after two selling quarters
260 buyers versus 317 sellers in 3q2025 is a lean away. if that flips, sentiment may be stabilizing before fundamentals do.
Analyst rankings
short-term outlook
below average
momentum score 4 — in human-speak, analysts think relative performance looks weak from here.
risk profile
average
stability score 3 — this sits near the middle of the pack on risk, not a bunker stock and not a chaos machine.
chart momentum
top 5%
technical score 1 — the tape looks stronger than the fundamentals. welcome to why momentum and earnings quality are not the same thing.
earnings predictability
30 / 100
low predictability means estimates move around more than you would like. this is a business where surprises are part of the package.
source: institutional data
Institutional activity

institutions have been net selling for 2 consecutive quarters — 260 buyers vs. 317 sellers in 3q2025. total institutional holdings: 0.2B shares. net selling for 2 quarters.

source: institutional data
Price targets
3-5 year target range
$45 $113
$89 current price
$79 target midpoint · 12% from current · 3-5yr high: $145 (+60% · 15% ann'l return)
source: institutional data · analyst targets

Want the deeper analysis?

The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

see plans from $5/mo
The deep dive
BG
xvary deep dive
bg
the full analysis is in the works.
what you'll get
dcf valuation model
bull / base / bear scenarios
competitive moat breakdown
quarterly earnings tracker
operating model projections
risk matrix with kill criteria
original price target + conviction
updated with every earnings
free · no spam · you'll be first to read it